» Articles » PMID: 34971353

Multidisciplinary Meetings in Interstitial Lung Disease: Polishing the Gold Standard

Overview
Specialty Pulmonary Medicine
Date 2021 Dec 31
PMID 34971353
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Multichannel CT and Radiomics-Guided CNN-ViT (RadCT-CNNViT) Ensemble Network for Diagnosis of Pulmonary Sarcoidosis.

Qiu J, Mitra J, Ghose S, Dumas C, Yang J, Sarachan B Diagnostics (Basel). 2024; 14(10).

PMID: 38786347 PMC: 11120014. DOI: 10.3390/diagnostics14101049.


Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives.

Cottin V, Martinez F, Smith V, Walsh S Eur Respir Rev. 2024; 31(165).

PMID: 38743511 PMC: 9724802. DOI: 10.1183/16000617.0003-2022.


Speaking of the "Devil": Diagnostic Errors in Interstitial Lung Diseases.

Arcana R, Crisan-Dabija R, Caba B, Zamfir A, Cernomaz T, Zabara-Antal A J Pers Med. 2023; 13(11).

PMID: 38003904 PMC: 10672616. DOI: 10.3390/jpm13111589.


An Artificial Intelligence Platform for the Radiologic Diagnosis of Pulmonary Sarcoidosis: An Initial Pilot Study of Chest Computed Tomography Analysis to Distinguish Pulmonary Sarcoidosis from a Negative Lung Cancer Screening Scan.

Judson M, Qiu J, Dumas C, Yang J, Sarachan B, Mitra J Lung. 2023; 201(6):611-616.

PMID: 37962584 DOI: 10.1007/s00408-023-00655-1.


Real-Life Diagnostic Performance of the Hypersensitivity Pneumonitis Guidelines: A Multicenter Cohort Study.

Freund O, Hadad Y, Shalmon T, Wand O, Schneer S, Perluk T Diagnostics (Basel). 2023; 13(14).

PMID: 37510080 PMC: 10377863. DOI: 10.3390/diagnostics13142335.


References
1.
Jo H, Troy L, Keir G, Chambers D, Holland A, Goh N . Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology. 2017; 22(7):1436-1458. DOI: 10.1111/resp.13146. View

2.
Mackintosh J, Glenn L, Barnes H, Dunn E, Bancroft S, Reddy T . Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology. 2021; 26(6):612-615. PMC: 8251432. DOI: 10.1111/resp.14062. View

3.
Richeldi L, Launders N, Martinez F, Walsh S, Myers J, Wang B . The characterisation of interstitial lung disease multidisciplinary team meetings: a global study. ERJ Open Res. 2019; 5(2). PMC: 6441673. DOI: 10.1183/23120541.00209-2018. View

4.
Jo H, Corte T, Moodley Y, Levin K, Westall G, Hopkins P . Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres. BMC Pulm Med. 2016; 16:22. PMC: 4736654. DOI: 10.1186/s12890-016-0179-3. View

5.
Walsh S, Wells A, Desai S, Poletti V, Piciucchi S, Dubini A . Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016; 4(7):557-565. DOI: 10.1016/S2213-2600(16)30033-9. View